This problem has a solution, and Pfizer is implementing it.

Pfizer (NYSE:PFE) news as US markets steady near records ahead of July CPI, with the drugmaker's pharmaceutical operations and healthcare stocks in focus.

Berobenatide is one of the keys to Pfizer's future.

Pfizer (NYSE:PFE) stays in focus as steadier inflation readings lift the broad market and cash-generative pharmaceutical ...

What comes to mind when you hear the word cancer? It may be surprising to learn there are many different definitions. That’s because cancer is not a single disease, but rather hundreds of different ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

It is definitely a strong contender.

LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after Pfizer struck a deal with Donald Trump's administration to ...

Add Yahoo as a preferred source to see more of our stories on Google. The recommendation, made by the CDC's Advisory Committee on Immunization Practices, acknowledges the increased risk of severe ...

Intent on growing its leading position in obesity and weight management drugs, Novo Nordisk has made an unsolicited, approximately up-to-$9 billion bid for Metsera—more than a month after Pfizer ...

Track Pfizer share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & loss ...